HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dimitrakopoulou-Strauss, A. Articles by van Kaick, G. Search for Related Content PubMed PubMed Citation Articles by Dimitrakopoulou-Strauss, A. Articles by van Kaick, G.

Intravenous and Intra-Arterial Oxygen-15-Labeled Water and Fluorine-18-Labeled Fluorouracil in Patients with Liver Metastases from Colorectal Carcinoma

Departments of Oncological Diagnostics and Therapy, Biophysics and Medical Radiation Physics and Radiochemistry and Radiopharmacology, German Cancer Research Center, Heidelberg; Department of Surgery and Surgical Oncology, Virchow-Klinikum, Robert-Rössle-Klinik, Berlin, Germany

Correspondence: For correspondence or reprints contact: Antonia Dimitrakopoulou-Strauss, MD, Department of Oncological Diagnostics and Therapy, German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany.

ABSTRACT

Intra-artenal chemotherapy can potentially increase drug delivery at the tumor sites and has therefore been used for the therapy of metastatic colorectal cancer. Methods: Dynamic PET and [¹⁸F]fluorouracil (¹⁸F-FU) were used in patients with liver metastases from colorectal cancer to examine the pharmacokinetics of the drug up to 120 min after intravenous and intra-arterial injection of the same dose of fluorouracil (FD). All patients included in the study (n = 15) had surgically implanted catheters in the gastroduodenal artery. Dynamic PET studies (up to 5 min) with 15O-labeled water were performed for the evaluation of the access to the lesions immediately before the ¹⁸F-FU study using both administration routes. The final evaluation included 24 metastases, obtained from 15 patients. Results: Of 24 lesions, 21 (87.5%) showed an improved access using the intra-arterial approach, and 20 (83.3%) demonstrated a better FU influx after intra-arterial ¹⁸F-FU infusion. Metastases reached the highest ¹⁸F-FU concentrations after intra-arterial administration, with a maximum standardized uptake values of 18.75 for the FU influx and of 5.03 for FU trapping. Of 24 metastases, eight (33.3%) demonstrated enhanced FU trapping after the intra-arterial administration. Cluster analysis revealed a group of metastases (n = 6) with a nonperfusion-dependent FU transport using the intravenous application. Of these six lesions, five (83.3%) did not show any enhancement of the ¹⁸F-FU trapping after intra-arterial application. The data gave evidence for at least one different, energy-dependent transport system, which can be saturated even after intravenous administration of the drug. Conclusion: The data show that the main limiting factor for a therapy response is the very high and rapid elimination of the cytostatic agent out of the tumor cells. Further more, it was not possible to predict the pharmacokinetics of FU after intra-arterial application using an intravenous PET study. It may be possible, using intravenous PET double-tracer studies, to identify metastases having a nonperfusion-dependent transport system and exclude them from an intra-arterial treatment protocol.

Key Words: PET • fluorine-18-fluorouracil • oxygen-15-water • liver metastases

This article has been cited by other articles:

				W.-A. Hsueh, A. L. Kesner, A. Gangloff, M. D. Pegram, M. Beryt, J. Czernin, M. E. Phelps, and D. H.S. Silverman Predicting Chemotherapy Response to Paclitaxel with 18F-Fluoropaclitaxel and PET J. Nucl. Med., December 1, 2006; 47(12): 1995 - 1999. [Abstract] [Full Text] [PDF]

				U. Metser 18F-FDG PET in Evaluating Patients Treated for Metastatic Colorectal Cancer: Can We Predict Prognosis? J. Nucl. Med., September 1, 2004; 45(9): 1428 - 1430. [Full Text] [PDF]

				A. Dimitrakopoulou-Strauss, L. G. Strauss, C. Burger, A. Ruhl, G. Irngartinger, W. Stremmel, and J. Rudi Prognostic Aspects of 18F-FDG PET Kinetics in Patients with Metastatic Colorectal Carcinoma Receiving FOLFOX Chemotherapy J. Nucl. Med., September 1, 2004; 45(9): 1480 - 1487. [Abstract] [Full Text] [PDF]

				J. R. Bading, P. B. Yoo, J. D. Fissekis, M. M. Alauddin, D. Z. D'Argenio, and P. S. Conti Kinetic Modeling of 5-Fluorouracil Anabolism in Colorectal Adenocarcinoma: A Positron Emission Tomography Study in Rats Cancer Res., July 1, 2003; 63(13): 3667 - 3674. [Abstract] [Full Text] [PDF]

				C. J. Hoekstra, S. G. Stroobants, O. S. Hoekstra, E. F. Smit, J. F. Vansteenkiste, and A. A. Lammertsma Measurement of Perfusion in Stage IIIA-N2 Non-Small Cell Lung Cancer Using H215O and Positron Emission Tomography Clin. Cancer Res., July 1, 2002; 8(7): 2109 - 2115. [Abstract] [Full Text] [PDF]

				M. A. Lodge, R. E. Carson, J. A. Carrasquillo, M. Whatley, S. K. Libutti, and S. L. Bacharach Parametric Images of Blood Flow in Oncology PET Studies Using [15O]Water J. Nucl. Med., November 1, 2000; 41(11): 1784 - 1792. [Abstract] [Full Text] [PDF]